Pancreatic exocrine insufficiency (PEI) & enzyme replacement
PEI, EPI, PERT, pancreatic enzyme replacement, steatorrhoea, maldigestion · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Inadequate pancreatic enzyme delivery to the duodenum causing fat/protein maldigestion: steatorrhoea, weight loss, bloating, fat-soluble vitamin deficiency. Commonest causes: chronic pancreatitis, pancreatic cancer/resection, cystic fibrosis, and after pancreatic/upper-GI surgery. Treated with pancreatic enzyme replacement therapy (PERT) plus nutritional support.
Red flags
- Progressive weight loss / failure to thrive despite PERT (reassess dose; exclude pancreatic cancer)
- New obstructive jaundice or back pain (pancreatic malignancy)
- Fat-soluble vitamin deficiency: bleeding (vit K), bone pain/fractures (vit D), visual/neurological signs
- Severe diarrhoea with dehydration
Assessment
Differential diagnosis
- Coeliac disease / small bowel mucosal malabsorption
- Bile acid diarrhoea / cholestasis
- Small intestinal bacterial overgrowth (SIBO)
- Inflammatory bowel disease (Crohn)
- Giardiasis, tropical sprue
- Short bowel syndrome
- Diabetic diarrhoea / autonomic neuropathy
Investigations
- Faecal elastase-1 (<200 microg/g suggests PEI; <100 severe) - main screening test, on formed stool
- Clinical features: steatorrhoea (pale, bulky, offensive, floating stool), weight loss, bloating
- Nutritional: FBC, albumin, HbA1c, fat-soluble vitamins (A, D, E) and INR (vitamin K), magnesium, zinc
- Imaging of pancreas (CT/MRCP/EUS) to define cause - chronic pancreatitis, tumour, ductal disease
- Bone density (DEXA) given fat-soluble vitamin malabsorption and osteoporosis risk
- Exclude coeliac disease (tTG-IgA) and SIBO if incomplete response
Management
- Confirm PEI (low faecal elastase + compatible clinical picture) and identify/treat underlying cause
- Start PERT with every meal and snack, dose by fat content and response (not a fixed small dose)
- Take enzymes DURING/with meals (spread through the meal), not before or after
- Add a PPI if response inadequate (raises duodenal pH so enteric coating releases enzymes properly)
- Optimise nutrition: do NOT fat-restrict; dietitian input, high-calorie diet, replace fat-soluble vitamins (A, D, E, K) and micronutrients
- Treat/monitor pancreatogenic (type 3c) diabetes if present
- Reassess symptoms, weight, and nutritional markers; up-titrate enzymes if steatorrhoea persists before concluding failure
Drugs & doses
Pancreatin (pancrelipase) 25,000-40,000 units lipase PO with each MAIN meal, and ~half that (10,000-25,000) with snacks; titrate up to effect (e.g. Creon)
Increase to 50,000-75,000 units lipase per meal if steatorrhoea persists before declaring treatment failure [verify local max]
Add PPI e.g. omeprazole 20-40 mg PO once daily if inadequate response (improves enzyme efficacy)
Fat-soluble vitamin replacement: vitamin A, D, E and K; e.g. colecalciferol for vitamin D deficiency; monitor levels
Cystic fibrosis dosing is weight-based per specialist CF guidance [verify local]
Dietitian-guided high-calorie diet; avoid unnecessary fat restriction
Disposition
Outpatient gastroenterology + dietitian. Admit only for severe malnutrition/dehydration or to investigate a suspected underlying malignancy.
Complications & pitfalls
- Malnutrition, sarcopenia, weight loss
- Fat-soluble vitamin (A, D, E, K) deficiency; osteoporosis/osteomalacia
- Fat-soluble vitamin K deficiency coagulopathy
- Type 3c (pancreatogenic) diabetes mellitus
- Increased cardiovascular and mortality risk if untreated
Exam pearls
- UK/BSG & UEG guidance: the commonest reason PERT 'fails' is UNDER-dosing, wrong timing (take WITH meals), or not adding a PPI - optimise all three before changing diagnosis.
- Do NOT put PEI patients on a low-fat diet - it worsens malnutrition and reduces the stimulus that PERT corrects.
- Faecal elastase-1 is the practical screening test but is falsely low on watery stool - test a formed sample.
- Always screen for and replace fat-soluble vitamins and arrange bone-density assessment.
- New or worsening PEI with weight loss and back pain in an older patient mandates imaging to exclude pancreatic cancer.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.